A J Green1, C J Johnson, K L Adamson
1Department of Oncology, Royal Free and University College Medical School, London, UK.
Optimizing antibody-targeted cancer therapy requires understanding key factors. Antibody affinity, tumor antibody flow, and elimination rates significantly impact treatment effectiveness and drug delivery.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: